Price/Earnings (Normalized) 19.15 Price/Sales 4.04 Dividend Yield (Trailing) 3.41% Dividend Yield (Forward) 3.43% Total Yield 4.02% Company Profile Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatit...
NewsProfileAnalyst Coverage5 Yr. FinancialsDividendsEarningsPrice HistoryEventsInsidersGilead Sciences Inc. News Finance News & Analysis Nov 3, 2024 7:16 PM EST Fed interest rate decision and election may roil stocks Trump, Harris, the Fed, and a bevy of earnings reports are on deck. PLTRAAPL...
A high-level overview of Gilead Sciences, Inc. (GILD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Analyst Price Target is $86.85 ▼-2.97% Downside Potential This price target is based on 23 analysts offering 12 month price targets for Gilead Sciences in the last 3 months. The average price target is $86.85, with a high forecast of $105.00 and a low forecast of $69.00. The average ...
11 hours ago Analysts revise Rivian stock price targets ahead of Q3 earnings Here’s what to expect in Rivian’s Nov. 7 earnings release. RIVNVWAGYAMZN Advanced Chart 1D 5D 3M 6M YTD 1Y 2Y 3Y 5Y 10Y chevron_right Frequency Daily
Get real-time updates on Gilead Sciences, Inc. Common Stock (GILD) stock quotes, trades, and more. Make informed investments with Nasdaq.
Discover real-time Gilead Sciences, Inc. Common Stock (GILD) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
She said $36,000 is a key support level for the cryptocurrency,whose price has been slidingsince the SEC approval of bitcoin ETFs on Jan. 10. It has fallen 12% since then and was trading at the $41,000 Monday morning. “I want to respect the uptrend behind bitcoin and the series of...
United Therapeutics stock price target raised to $263 from $236 at Wedbush May. 24, 2022 at 7:14 a.m. ET by Tomi Kilgore United Therapeutics stock price target cut to $236 from $276 at Wedbush Feb. 28, 2022 at 7:58 a.m. ET by Tomi Kilgore Pig-to-human organ transplants ...
Novo Nordisk A/S 0.95% kr.3.32T AbbVie Inc. -0.44% $302.34B AstraZeneca PLC ADR -0.79% $197.68B AstraZeneca PLC 1.54% £154.88B Moderna Inc. -2.46% $16.73B Gilead Sciences Inc. -1.96% $117.46B Regeneron Pharmaceuticals Inc. -1.51% $90.22B Lonza Group AG -0.14% CHF40.26BAdvertisem...